- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05169047
Underterskel SCS eller BMT (TRADITION)
Den holistiske responsen til pasienter med vedvarende ryggmargsmertesyndrom type II ved subterskel ryggmargsstimulering sammenlignet med beste medisinske behandling, undersøkt av en multisentrisk randomisert kontrollert studie
Given the substantial socioeconomic impact of Spinal Cord Stimulation (SCS) implantations and given that currently no direct high-quality evidence with a relevant outcome measurement is available to guide the treatment choice between subthreshold SCS versus best medical treatment in patients with Persistent Spinal Pain Syndrome Type 2 (PSPS-T2), we here propose a scientifically well-constructed randomized controlled trial to answer this question.
The primary scientific objective is to examine whether subthreshold SCS, compared to best medical treatment, provided to patients with PSPS-T2 results in a higher percentage of clinical holistic responders at 6 months. The secondary objective of the study is to examine if subthreshold SCS compared with BMT is having more efficacy in improving patients' individual competencies for self-management, increasing the likelihood to return to work, work status and healthcare expenditure, improving pain relief, obtaining pain medication reduction, decreasing anxiety and depression, increasing quality of life and decreasing disability.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
After filling in the questionnaires at the 6 months follow-up visit, patients could change treatment groups (in both directions). This decision will be a shared decisions between patient and treating physician in case the randomized intervention did not provided enough pain relief.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Jette, Belgia, 1090
- Universitair Ziekenhuis Brussel
-
Mechelen, Belgia
- Emmaüs, AZ Sint-Maarten
-
Roeselare, Belgia
- AZ Delta
-
Turnhout, Belgia
- AZ Turnhout
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Persistent Spinal Pain Syndrome Type II (PSPS-T2)
- Chronic pain as a result of PSPS-T2 that exists for at least 6 months with a pain intensity of at least 4/10 on the Numeric Rating Scale, refractory to conservative treatment.
- PSPS-T2 patients eligible for subthreshold SCS
- Age > 18 years
- Patient has been informed of the study procedures and has given written informed consent
- Patient willing to comply with study protocol including attending the study visits
Exclusion Criteria:
- Expected inability of patients to receive or properly operate the spinal cord stimulation system
- Evidence of an active psychiatric disorder
- Suffering from another chronic illness characterised by chronic generalized widespread pain (e.g. rheumatoid arthritis, fibromyalgia, chronic fatigue syndrome, scleroderma).
- Pregnancy
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Beste medisinske behandling
|
For each patient who is randomized to BMT, an optimal individual treatment plan will be developed by the treating physician. |
|
Aktiv komparator: Underterskel ryggmargsstimulering
|
SCS will be programmed at subthreshold stimulation. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Clinical holistic responder status
Tidsramme: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
The clinical holistic responder status as a composite measure represents the global effect of a treatment, based on a combination of questionnaires. |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Overall pain intensity with Visual Analogue Scale (VAS)
Tidsramme: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Overall pain, defined as a combination of back and leg pain, but not pain from other body parts, measured with the VAS (100mm) |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Pain medication use
Tidsramme: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Open question regarding the dosage, frequency and type of pain medication |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Functional disability
Tidsramme: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
The functional disabilities will be assessed with the Oswestry Disability Index (ODI) |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Health related quality of life
Tidsramme: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Health related quality of life, evaluated with the EuroQol with five dimensions and 5 levels |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Patient global impression of change
Tidsramme: Evaluated at 1 month, 6 months and 12 months.
|
Patients will be asked to quantify the impression of change after treatment using the Patient Global Impression of Change scale (PGIC). |
Evaluated at 1 month, 6 months and 12 months.
|
|
Work status
Tidsramme: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Work status is evaluated with a self-designed questionnaire |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Patients' individual competencies for self-management
Tidsramme: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Patient activation measure-13 (PAM) is a 13-item instrument which assesses self-reported behaviour, knowledge, and confidence for self-management of one's health. |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Healthcare utilisation.
Tidsramme: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Healthcare expenditure will be investigated by self-reporting methods. |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Anxiety and Depression.
Tidsramme: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
The hospital Anxiety and Depression Scale (HADS) will measure symptoms of anxiety and depression |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Samarbeidspartnere og etterforskere
Sponsor
Publikasjoner og nyttige lenker
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- TRADITION
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .